{"componentChunkName":"component---node-modules-gatsby-theme-buzzing-src-gatsby-theme-blog-core-templates-post-query-js","path":"/ja/reddit/r/investing/comments/o2043p/opinions_on_atossa_therapeutics_atos/","result":{"data":{"site":{"siteMetadata":{"title":"国外股市热门","author":"Buzzing.cc","description":"用中文浏览国外股票社区里的热门讨论","keywords":["buzzing","美股","股票","股市"],"siteUrl":"https://stocks.buzzing.cc","telegram":"@stocks_top","iconUrl":"https://stocks.buzzing.cc/avatar.png","defaultSocialImageUrl":null,"social":[{"name":"Reddit Stocks","url":"https://www.reddit.com/r/stocks","external":true},{"name":"Reddit Investing","url":"https://www.reddit.com/r/investing","external":true},{"name":"Charlie Bilello's twitter","url":"https://twitter.com/charliebilello","external":true},{"name":"Buzzing","url":"https://www.buzzing.cc/","external":true}],"menuLinks":[{"name":"每周精选","url":"/issues","external":null}],"disqus":null,"utterances":null,"localize":[{"title":"Buzzing on Stocks","description":"See popular discussions in foreign stock communities in your native language","keywords":["buzzing","stocks","U.S. stocks"],"locale":"en","social":{"name":null,"url":null,"external":null},"menuLinks":[{"name":"Weekly Selection","url":"/en/issues","external":null}]},{"title":"國外股市熱門","description":"用中文瀏覽國外股票社區裡的熱門討論","keywords":["buzzing","美股","股票","股市"],"locale":"zh-Hant","social":null,"menuLinks":[{"name":"每週精選","url":"/zh-Hant/issues","external":null}]},{"title":"米国株式市場人気の話し合います","description":"人気の米国株式市場の話し合いまを日本語で閲覧","keywords":["buzzing","米国株式市場"],"locale":"ja","social":null,"menuLinks":[]}]}},"blogPost":{"id":"RedditPost-795442e3-07cb-518f-a865-d84014218c98","excerpt":"Atossa Therapeutics is a clinical-stage biopharmaceutical company working on\ninnovative medicines and treatments for breast cancer (Endoxifen) and COVID-19.\n\nI'm a nutrition science / biopharma student and was reading pappers about breast\ncancer and found that ATOS had a \" A statistically…","body":"<!-- SC_OFF --><div class=\"md\"><p>Atossa Therapeutics is a clinical-stage biopharmaceutical company working on innovative medicines and treatments for breast cancer (Endoxifen) and COVID-19.</p>\n\n<p>I&#39;m a nutrition science / biopharma student and was reading pappers about breast cancer and found that ATOS had a &quot; <strong>A statistically significant (p = 0.031) reduction of about 74% in tumor cell proliferation was achieved over an average of 22 days of dosing</strong> &quot; on there phase II <a href=\"https://www.globenewswire.com/en/news-release/2020/05/13/2032759/0/en/Atossa-Therapeutics-Announces-First-Quarter-2020-Financial-Results-and-Provides-Company-Update-on-COVID-19-HOPE-and-Endoxifen-Programs.html\">study</a>.</p>\n\n<p>They also had a <a href=\"https://www.abstractsonline.com/pp8/#!/7946/presentation/2006\">28% increase in progression-free survival</a> (the amount of time during and after treatment that the disease doesn&#39;t progress).</p>\n\n<h1>Financials</h1>\n\n<p>They have <strong>138M in cash</strong> and have <strong>no debt</strong>, they spend <strong>3.51M per quarter</strong>, via Q1 2021 <a href=\"https://atossatherapeutics.com/atossa-therapeutics-announces-first-quarter-2021-financial-results-and-provides-corporate-update/\">report</a>.</p>\n\n<p>&#x200B;</p>\n\n<p>They are also being added to the <a href=\"https://content.ftserussell.com/sites/default/files/russell_3000_index_additions_-_2021.pdf\">Russell 3000 index</a>.</p>\n\n<p>&#x200B;</p>\n\n<p>As a student more or less in the same field of work I really like the upside on this company.</p>\n\n<p>But what is your opinion?</p>\n\n<p>&#x200B;</p>\n\n<p>Full disclosure: 11 shares @ 4.5USD (i know its not much but its honest work for a college student)</p>\n\n<p>&#x200B;</p>\n\n<p>EDIT1: as i finish this post ATOS is <strong>up ~14% on the day</strong>, i gess nobody is sleeping on this stock after all.</p>\n</div><!-- SC_ON -->","slug":"/reddit/r/investing/comments/o2043p/opinions_on_atossa_therapeutics_atos/","title":"Opinions on Atossa Therapeutics (ATOS)","tags":["investing","reddit"],"date":"June 17, 2021","dateISO":"2021-06-17T17:52:47.000Z","datetime":"2021-06-17 17:52","image":null,"imageAlt":null,"socialImage":null,"__typename":"SocialMediaPost","thirdPartyId":"795442e3-07cb-518f-a865-d84014218c98","provider":"Reddit","url":"https://www.reddit.com/r/investing/comments/o2043p/opinions_on_atossa_therapeutics_atos/","originalUrl":"https://www.reddit.com/r/investing/comments/o2043p/opinions_on_atossa_therapeutics_atos/","imageRemote":null,"video":null,"channel":"investing","channelUrl":"https://www.reddit.com/r/investing","author":"CooterThug_69","authorUrl":"https://www.reddit.com/user/CooterThug_69","authorImage":null,"authorImageRemote":null,"authorSlug":"CooterThug_69","score":146,"views":null,"sharedCount":null,"likeCount":null,"sharedContent":null,"parent":{"localize":[{"title":"Atossa Therapeutics（ATOS）に対する意見","the_new_excerpt":"Atossa Therapeuticsは、乳がんに対する革新的な医薬品と治療法（EndoxifenとCOVID-19）の開発に取り組んでいる臨床段階のバイオ医薬品企業です。\nエンドキシフェンやCOVID-19などの革新的な乳がん治療薬を開発しています。\n\n私は栄養学とバイオファーマを専攻している学生で、乳がんについての論文を読んでいました。\n私は栄養学／バイオファーマの学生ですが、乳がんについての論文を読んでいて、ATOSが「統計的に...」と書いてあるのを見つけました。","locale":"ja"},{"title":"关于Atossa Therapeutics (ATOS)的观点","the_new_excerpt":"Atossa Therapeutics是一家处于临床阶段的生物制药公司，致力于开发治疗乳腺癌（Endoxifen和COVID-19）的创新药物和疗法。\n创新药物和治疗乳腺癌（Endoxifen）和COVID-19。\n\n我是一名营养学/生物制药专业的学生，在阅读有关乳腺癌的论文时，发现ATOS在统计学上有 \"A\"。\n我是一名营养学/生物制药专业的学生，在阅读有关乳腺癌的论文时发现，ATOS有一个 \"A统计学\"。","locale":"zh"},{"title":"關於Atossa Therapeutics (ATOS)的觀點","the_new_excerpt":"Atossa Therapeutics是一家處於臨牀階段的生物製藥公司，致力於開發治療乳腺癌（Endoxifen和COVID-19）的創新藥物和療法。\n創新藥物和治療乳腺癌（Endoxifen）和COVID-19。\n\n我是一名營養學/生物製藥專業的學生，在閱讀有關乳腺癌的論文時，發現ATOS在統計學上有 \"A\"。\n我是一名營養學/生物製藥專業的學生，在閱讀有關乳腺癌的論文時發現，ATOS有一個 \"A統計學\"。","locale":"zh-Hant"}]}},"previous":{"id":"RedditPost-869fe429-246c-5175-9fea-7095be521687","excerpt":"Is anyone taking a look at the new Invesco SOXQ Semiconductor ETF?\n\nhttps://www.invesco.com/us/financial-products/etfs/product-detail?audienceType=Investor&ticker=SOXQ\n\nIt just started trading on June 11th and in order to compete against the\nwell-established semiconductor, ETFs like SOXX and SMH…","slug":"/reddit/r/investing/comments/o1yq8j/soxq_new_invesco_semiconductor_etf_with_0_fees/","title":"SOXQ - New Invesco Semiconductor ETF with 0% Fees until December","date":"June 17, 2021","__typename":"SocialMediaPost","parent":{"localize":[{"title":"SOXQ - 12月まで手数料0％の新インベスコ・セミコンダクターETF","the_new_excerpt":"新しいInvesco SOXQ Semiconductor ETFを見ている人はいますか？\n\nhttps://www.invesco.com/us/financial-products/etfs/product-detail?audienceType=Investor&ticker=SOXQ\n\n6月11日に取引が開始されたばかりで、SOXXやSMHのような老舗の半導体ETFに対抗するためのものです。\nSOXXやSMHのような老舗の半導体ETFに対抗するために...。","locale":"ja"},{"title":"SOXQ - 新的Invesco半导体ETF，12月前费用为0","the_new_excerpt":"有人在看新的Invesco SOXQ半导体ETF吗？\n\nhttps://www.invesco.com/us/financial-products/etfs/product-detail?audienceType=Investor&ticker=SOXQ\n\n它在6月11日刚刚开始交易，为了与历史悠久的半导体ETF竞争\n完善的半导体ETF，如SOXX和SMH...","locale":"zh"},{"title":"SOXQ - 新的Invesco半導體ETF，12月前費用爲0","the_new_excerpt":"有人在看新的Invesco SOXQ半導體ETF嗎？\n\nhttps://www.invesco.com/us/financial-products/etfs/product-detail?audienceType=Investor&ticker=SOXQ\n\n它在6月11日剛剛開始交易，爲了與歷史悠久的半導體ETF競爭\n完善的半導體ETF，如SOXX和SMH...","locale":"zh-Hant"}]}},"next":{"id":"TweetPost-1405572462633492481","excerpt":"","slug":"/tweet/1405572462633492481","title":"📈📈📈 https://t.co/pr4nheKfrp","__typename":"SocialMediaPost","date":"June 17, 2021","parent":{"localize":[{"locale":"ja","full_text":"📈📈📈 https://t.co/pr4nheKfrp","quoted_status_full_text":null,"retweeted_status_full_text":null},{"locale":"zh","full_text":"📈📈📈https://t.co/pr4nheKfrp","quoted_status_full_text":null,"retweeted_status_full_text":null},{"locale":"zh-Hant","full_text":"📈📈📈https://t.co/pr4nheKfrp","quoted_status_full_text":null,"retweeted_status_full_text":null}]}}},"pageContext":{"basePath":"/","pageType":"detail","id":"RedditPost-795442e3-07cb-518f-a865-d84014218c98","previousId":"RedditPost-869fe429-246c-5175-9fea-7095be521687","nextId":"TweetPost-1405572462633492481","maxWidth":1024,"siteMetadata":null,"locale":"ja","hrefLang":"ja-JA","originalPath":"/reddit/r/investing/comments/o2043p/opinions_on_atossa_therapeutics_atos/","dateFormat":"YYYY-MM-DD"}},"staticQueryHashes":["1239077767","2744905544","3280999885"]}